Peritoneal Membrane Function in Myeloma

Acute and chronic renal failure and infections are frequent complications of patients affected by multiple myeloma.(1) Besides pharmacological therapy, plasma exchange and dialysis have been employed for treatment of renal failure.(2–4) However, some authors report a poor survival of these patients and indicate the replacement therapy only for those responsive to chemotherapy.(5–7) In this study, we review our 8 years of experience in treating uremia due to myeloma by using continuous ambulatory peritoneal dialysis (CAPD) as first approach.